TY - JOUR
T1 - CellNet
T2 - Network biology applied to stem cell engineering
AU - Cahan, Patrick
AU - Li, Hu
AU - Morris, Samantha A.
AU - Lummertz Da Rocha, Edroaldo
AU - Daley, George Q.
AU - Collins, James J.
N1 - Funding Information:
J.J.C. is supported by NIH grant R24DK092760 and the HHMI. G.Q.D. is supported by grants from the NIH (Progenitor Cell Biology Consortium UO1-HL100001, R24DK092760, and P50HG005550), the Ellison Medical Foundation, Doris Duke Medical Foundation, and Boston Children's Hospital Stem Cell Program, and is an affiliate member of the Broad Institute. P.C. is supported by NIDDK (K01DK096013) and received support from NHLBI (T32HL066987 and T32HL007623). S.A.M. is supported by a Young Investigator Award from Alex’s Lemonade Stand Foundation. H.L. is supported by Mayo Clinic Center for Individualized Medicine and Mayo Clinic Center for Regenerative Medicine. E.L.d.R. is supported by National Council for Scientific and Technological Development and the program Science Without Borders (CNPq, Brazil).
PY - 2014/8/14
Y1 - 2014/8/14
N2 - Somatic cell reprogramming, directed differentiation of pluripotent stem cells, and direct conversions between differentiated cell lineages represent powerful approaches to engineer cells for research and regenerative medicine. We have developed CellNet, a network biology platform that more accurately assesses the fidelity of cellular engineering than existing methodologies and generates hypotheses for improving cell derivations. Analyzing expression data from 56 published reports, we found that cells derived via directed differentiation more closely resemble their in vivo counterparts than products of direct conversion, as reflected by the establishment of target cell-type gene regulatory networks (GRNs). Furthermore, we discovered that directly converted cells fail to adequately silence expression programs of the starting population and that the establishment of unintended GRNs is common to virtually every cellular engineering paradigm. CellNet provides a platform for quantifying how closely engineered cell populations resemble their target cell type and a rational strategy to guide enhanced cellular engineering.
AB - Somatic cell reprogramming, directed differentiation of pluripotent stem cells, and direct conversions between differentiated cell lineages represent powerful approaches to engineer cells for research and regenerative medicine. We have developed CellNet, a network biology platform that more accurately assesses the fidelity of cellular engineering than existing methodologies and generates hypotheses for improving cell derivations. Analyzing expression data from 56 published reports, we found that cells derived via directed differentiation more closely resemble their in vivo counterparts than products of direct conversion, as reflected by the establishment of target cell-type gene regulatory networks (GRNs). Furthermore, we discovered that directly converted cells fail to adequately silence expression programs of the starting population and that the establishment of unintended GRNs is common to virtually every cellular engineering paradigm. CellNet provides a platform for quantifying how closely engineered cell populations resemble their target cell type and a rational strategy to guide enhanced cellular engineering.
UR - http://www.scopus.com/inward/record.url?scp=84908446782&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2014.07.020
DO - 10.1016/j.cell.2014.07.020
M3 - Article
C2 - 25126793
AN - SCOPUS:84908446782
SN - 0092-8674
VL - 158
SP - 903
EP - 915
JO - Cell
JF - Cell
IS - 4
ER -